Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients oleh Marie-Lorraine Chretien, Benjamin Hebraud, Valérie Cances-Lauwers, Cyrille Hulin, Gerald Marit, Xavier Leleu, Lionel Karlin, Murielle Roussel, Anne-Marie Stoppa, Francois Guilhot, Thierry Lamy, Laurent Garderet, Brigitte Pegourie, Mamoun Dib, Catherine Sebban, Pascal Lenain, Sabine Brechignac, Bruno Royer, Marc Wetterwald, Laurence Legros, Frédérique Orsini-Piocelle, Laurent Voillat, Xavier Delbrel, Denis Caillot, Margaret Macro, Thierry Facon, Michel Attal, Philippe Moreau, Hervé Avet-Loiseau, Jill Corre